Correlation Between Syndax Pharmaceuticals and Zymeworks Common

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Zymeworks Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Zymeworks Common into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Zymeworks Common Stock, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Zymeworks Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Zymeworks Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Zymeworks Common.

Diversification Opportunities for Syndax Pharmaceuticals and Zymeworks Common

0.21

Correlation Coefficient

Syndax Pharmaceuticals  Zymeworks Common

Modest diversification

The 3 months correlation between Syndax and Zymeworks is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Zymeworks Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zymeworks Common Stock and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Zymeworks Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zymeworks Common Stock has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Zymeworks Common go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Zymeworks Common

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.99 times more return on investment than Zymeworks Common. However, Syndax Pharmaceuticals is 1.01 times less risky than Zymeworks Common. It trades about 0.06 of its potential returns per unit of risk. Zymeworks Common Stock is currently generating about -0.06 per unit of risk. If you would invest  1,252  in Syndax Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  104.00  from holding Syndax Pharmaceuticals or generate 8.31% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Zymeworks Common Stock

Syndax Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Syndax Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain fundamental indicators, Syndax Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Zymeworks Common Stock

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zymeworks Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Syndax Pharmaceuticals and Zymeworks Common

The main advantage of trading using opposite Syndax Pharmaceuticals and Zymeworks Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Zymeworks Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zymeworks Common will offset losses from the drop in Zymeworks Common's long position.

The idea behind Syndax Pharmaceuticals and Zymeworks Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.